These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7772519)

  • 1. The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).
    Rose EH; Abels RI; Nelson RA; McCullough DM; Lessin L
    Br J Haematol; 1995 Apr; 89(4):831-7. PubMed ID: 7772519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes.
    Adamson JW; Schuster M; Allen S; Haley NR
    Acta Haematol; 1992; 87 Suppl 1():20-4. PubMed ID: 1574963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
    Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anemia in low risk myelodysplastic syndromes with granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin.
    Economopoulos T; Mellou S; Papageorgiou E; Pappa V; Kokkinou V; Stathopoulou E; Pappa M; Raptis S
    Leukemia; 1999 Jul; 13(7):1009-12. PubMed ID: 10400415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia.
    van Kamp H; Prinsze-Postema TC; Kluin PM; den Ottolander GJ; Beverstock GC; Willemze R; Fibbe WE
    Br J Haematol; 1991 Aug; 78(4):488-93. PubMed ID: 1911340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of intravenous recombinant erythropoietin for the treatment of anaemia in myelodysplastic syndrome.
    Goy A; Belanger C; Casadevall N; Picard F; Guesnu M; Jaulmes D; Poisson D; Varet B
    Br J Haematol; 1993 Jun; 84(2):232-7. PubMed ID: 8398823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.
    Hellström-Lindberg E; Negrin R; Stein R; Krantz S; Lindberg G; Vardiman J; Ost A; Greenberg P
    Br J Haematol; 1997 Nov; 99(2):344-51. PubMed ID: 9375752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin.
    Bowen D; Culligan D; Jacobs A
    Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.
    Stein RS; Abels RI; Krantz SB
    Blood; 1991 Oct; 78(7):1658-63. PubMed ID: 1912554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose recombinant human erythropoietin administered intravenously for the treatment of anaemia in myelodysplastic syndromes.
    Casadevall N; Belanger C; Goy A; Varet B; Lang J; Poisson D
    Acta Haematol; 1992; 87 Suppl 1():25-7. PubMed ID: 1574964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
    Chiou TJ; Chim YS; Wei CH; Hsieh RK; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):229-35. PubMed ID: 9509677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
    Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
    Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of r-HuEPO.
    Eschbach JW
    Nephrol Dial Transplant; 1995; 10 Suppl 2():96-109. PubMed ID: 7644114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
    Abels RI
    Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.